Portfolio Companies
Tools:
|
Alpha Innotech, , Biocompare, Epitomics, Fermentas, Genewiz, Panomics, SuperArray
Biosciences, System Biosciences
|
Drug Development:
|
BioKey, Optimer Pharmaceuticals, StemCyte, TP
Therapeutics
|
Diagnostics:
|
Advanced Cell Diagnostics, Diagcor, Diagnostic Hybrids (DHI),
|
Medical Devices
|
BioForm
|
Other:
|
|

|
Alpha Innotech
www.alphainnotech.com
San Leandro, California
Alpha Innotech is providing complete imaging
solutions for the genetic research and drug discovery markets. The company was
acquired by Cell Biosciences in Santa Clara, California in October 2009.
|

|
Advanced Cell Diagnostics, Inc.
http://www.acdbio.com
Advanced Cell Diagnostics, Inc. (ACD) is a leader in
the emerging field of molecular pathology, developing cell- and
tissue-based diagnostic tests for personalized medicine. ACD’s
products and services are based on its proprietary RNAscope®
Technology, the first multiplex fluorescent and chromogenic in
situ hybridization platform capable of detecting and quantifying
RNA biomarkers in situ at single molecule sensitivity. The company was acquired by Bio-Techne (NASDAQ: TECH) in August, 2016.
|

|
Apexigen, Inc.
www.apexigen.com
Burlingame, California
Apexigen™ is a
biopharmaceutical product development company pioneering the next
generation of antibody drugs. With the use of proprietary platform
technology based on humanized rabbit-derived antibodies, the company
seeks to aid in the discovery and development of better treatments for serious
and difficult to treat diseases.
|

|
BioForm Mediacl, Inc.
www.bioform.com
San Mateo, California
BioForm Medical, Inc. (NASDAQ: BFRM) is a
medical device company developing and commercializing a family of
proprietary injectable implant products for the treatment of certain
illness as well as for the use in cosmetic tissue augmentation. The company went public in November 2007.
|

|
BioKey,
Inc.
www.biokeyinc.com
Fremont, California
BioKey is using controlled release platform
technologies to develop and market generic drugs and accelerated new drug
application (NDA) products.
|
|
|

|
DiagCor Bioscience Inc.
Limited
www.diagcor.com
Hong Kong, PRC
Diagcor develops and commercializes in vitro
diagnostic kits and instrumentations using company's proprietary platform
technology. Moreover, DiagCor utilizes
its forefront expertise to build the genomic testing diagnostic service
network in Mainland China and Asia Pacific Region.
|

|
Diagnostic Hybrids, Inc.
www.dhiusa.com
Athens, Ohio
Diagnostic Hybrids develops, manufactures, and markets diagnostic cell
cultures and virus detection kit systems used in the clinical diagnosis
of infectious and autoimmune diseases.
The company was acquired by Quidel (NASDAQ: QDEL) in January 2010.
|

|
Epitomics,
Inc.
www.epitomics.com
South San Francisco, California
Epitomics, Inc., an emerging biotechnology
company, is dedicated to developing proprietary Rabbit
monoclonal antibody technology (MAb) to
the research and the therapeutic markets. Its Rabbit monoclonal
technology is considered the pioneer in the monoclonal antibody area and
is becoming increasingly popular among end-users. The Company was
acquired by Abcam PIc
(London: ABC) in April 2012.
|


|
Fermentas,
Inc.
www.fermentas.com
Burlington, Onterio, Canada
Fermentas is a leader in the discovery,
manufacturing, and marketing of high quality molecular biology products
for life sciences research community worldwide. Product offerings include
FastDigest restriction enzymes, DNA/RNA
modifying enzymes, DNA/protein purification kits, reagents for use in
PCR, cloning, and sequencing, etc.
The company was acquired by Thermo Fisher
Scientific (NYSE: TMO) in May 2010.
Genewiz
http://www.genewiz.com/
South Plainfield, New Jersey
GENEWIZ is a leading global genomics service company.
A full-service provider, GENEWIZ provides DNA sequencing, gene synthesis,
molecular biology, next generation sequencing, bioinformatics, and GLP
regulatory services. Excelling in both science and customer
support, GENEWIZ is dedicated to accelerating scientific discovery, as
well as to developing and delivering innovative solutions for
translational medicine and healthcare.
|

|
Optimer
www.optimerpharma.com
San Diego, California
Optimer (NASDAQ: OPTR) is developing novel
carbohydrate chemistry to attack antibiotics-resistant bacteria.
Currently, the company has 2 proprietary antibiotics under late stage of
clinical trials. The company went public in
February 2007.
|

|
Panomics
www.panomics.com
Fremont, California
Panomics is developing and marketing novel and
innovative tools for the molecular and cell biology research
fields. Panomics has merged with Genospectra in 2006 forming a new entity. The
new company currently operates under the name Panomics.
The new company was acquired by Affymetrix (NASDAQ: Affx)
in December 2008.
|

|
StemCyte
www.stemcyte.com
Acadia, California
StemCyte specializes in cord blood stem cell technology
including transplantation therapy, diagnostics, and research.
|

|
SuperArray
Biosciences
www.superarray.com
Frederick, Maryland
SuperArray, Inc. is a fast-growing company
dedicated to providing life scientists and biomedical researchers with
cutting edge array technology and a number of innovative research tools
to advance functional studies. The company was
acquired by Qiagen (NASDAQ: QGEN) in December
2009.
|


|
System Biosciences
www.systembio.com
Mountain View, California
System Biosciences focuses on developing unique and proprietary siRNA and
microRNA technologies that provide life science researchers with tools to
investigate gene functions.
TP Therapeutics
http://www.tptherapeutics.com/
San Diego, California
TP Therapeutics, Inc. (TP) is
a structure-based drug design company for the discovery and development
of precision medicines for cancer and other diseases. They focus on the
design of novel chemical identities for established oncogene drivers with
secondary resistant mutations, newly identified disease-driven targets,
and potential targets regulating tumor microenvironment and tumor
immunity.
|
|
|